source https://www.pharmatutor.org/pharma-news/2020/new-oral-treatment-for-moderate-to-severe-atopic-dermatitis
Subscribe to:
Post Comments (Atom)
-
Results from a clinical trial published in 2011 confirmed the benefit of using Avastin over laser therapy for treating the most severe c...
-
The National Institutes of Health announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19...
-
Merck Announces molnupiravir data which required less Acute Care Visit Merck, known as MSD outside the United States and Canada, and Ridg...
No comments:
Post a Comment